← Leaderboards
Jennifer Joy Smith
Precyte, Inc.
$7,580,161
Attributed
$7,580,161
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2015–21$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,580,161 · 4
By mechanism
R44$6,980,777 · 2
R43$599,384 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCellsCultured CellsDiagnosisDiagnosticBiosensorBaseGenesS DiseaseSamplingBloodResponseGene ExpressionSignal TransductionEarly DiagnosisDetectionTrainingBlood SpecimenPatternCohortBlindCost EffectiveSerumValidation
Grant awards (10)
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer$488,587
R44 · FY2021 · CA · contact PI
Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimer's Disease$998,853
R44 · FY2020 · AG · contact PI
Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimer's Disease$998,853
R44 · FY2019 · AG · contact PI
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer$509,200
R44 · FY2019 · CA · contact PI
Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimer's Disease$996,801
R44 · FY2018 · AG · contact PI
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer$996,232
R44 · FY2018 · CA · contact PI
Rational drug selection for Alzheimer's disease using Indicator Cell Assay Platform (iCAP)$299,437
R43 · FY2017 · AG · contact PI
Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimers Disease$840,407
R44 · FY2016 · AG · contact PI
Development of an Indicator Cell Assay for blood-based diagnosis of lung cancer$299,947
R43 · FY2016 · CA · contact PI
Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimers Disease$1,151,844
R44 · FY2015 · AG · contact PI